NIH-funded research U01 cooperative agreement

Improving health outcomes for patients with inflammatory bowel disease.

Official title: RFA-DP-23-002, Improving Outcomes and Reducing Disparities for Patients with Inflammatory Bowel Disease through Epidemiology, Enhanced Disease Management, Dissemination, and Education

Funded at Univ of North Carolina Chapel Hill · NIH-10895259 · Data updated 2026-11-12

This study is looking at how things like your social life and support can impact the health of people with inflammatory bowel disease (IBD), like Crohn's disease and ulcerative colitis, and it will involve 1,200 participants trying out new ways to improve care while also creating helpful resources for patients and doctors.

More Inflammatory Bowel Disease research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 30, 2023
Project endSeptember 29, 2028
Funding year2024
Award (this year)$774,997
NIH project number5U01DP006745-02
Project IDNIH-10895259 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include children aged 13-17 and adults over 17 who are diagnosed with inflammatory bowel disease.

Less likely to help

Patients with inflammatory bowel disease who are not willing or able to participate in a clinical trial may not benefit from this research.

What this research studies

This research focuses on understanding how social factors affect the health of individuals with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. It aims to improve patient care through a multi-center clinical trial involving 1,200 participants, where innovative management strategies will be tested alongside a study of social determinants impacting disease outcomes. The project will also develop educational programs for both patients and healthcare providers to enhance awareness and treatment effectiveness.

Why it matters

Potential benefit: If successful, this research could lead to improved quality of life and reduced health disparities for patients with inflammatory bowel disease.

How similar studies have gone: Previous research has shown that addressing social determinants of health can significantly improve outcomes in chronic disease management, suggesting a promising approach in this area.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Kappelman, Michael D — Univ of North Carolina Chapel Hill
  • Study coordinator: Kappelman, Michael D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.